Filtered By:
Condition: Diabetes
Countries: Canada Health

This page shows you your search results in order of relevance. This is page number 12.

Order by Relevance | Date

Total 188 results found since Jan 2013.

The impact of first wave of the SARS-CoV-2 2019 pandemic in Poland on characteristics and outcomes of patients hospitalized due to stable coronary artery disease
CONCLUSIONS: The SARS-CoV-2 2019 pandemic affected the characteristics and hospitalization course of stable angina patients hospitalized following the first wave. The hospitalization outcome was similar in the analyzed time intervals. The higher prevalence of comorbidities raises concern regarding upcoming years.PMID:36200545 | DOI:10.5603/CJ.a2022.0094
Source: Cardiology Journal - October 6, 2022 Category: Cardiology Authors: Justyna Jankowska-Sanetra Krzysztof Sanetra Marta Konopko Monika Kutowicz Magdalena Synak Krzysztof Milewski Pawe ł Kaźmierczak Łukasz Kołtowski Piotr P Buszman Source Type: research

Cardiometabolic Multimorbidity and Activity Limitation Among Older Canadians
To i) estimate the prevalence of activity limitation among Canadians with cardiometabolic multimorbidity (CM); and ii) to quantify the association between CM and activity limitation. Cardiometabolic multimorbidity is the diagnosis of two or more of stroke, heart disease and diabetes.
Source: Archives of Physical Medicine and Rehabilitation - December 1, 2022 Category: Rehabilitation Authors: Nicole Ketter, Christopher Brinton, Jodi Siever, Brodie Sakakibara Tags: Research Poster 2184269 Source Type: research

Macrocytosis in Mitochondrial DNA Deletion Syndromes
Large single mtDNA (mitochondrial DNA) deletion syndrome is a rare inborn error of metabolism with variable heteroplasmy levels and clinical phenotype among affected individuals. Chronic progressive external ophthalmoplegia (CPEO) is the most common phenotype in adults with this form of mitochondrial disease [1-2]. The common CPEO clinical manifestations are ptosis and ophthalmoplegia. More variable phenotypic manifestations of CPEO (CPEO plus) include involvement of the peripheral nervous system and myopathy. Here, we describe a 62-year-old female with CPEO and the major mitochondrial DNA deletion present at 40% heteropla...
Source: Acta Haematologica - February 10, 2023 Category: Hematology Source Type: research